Lymph node metastases >5 and metastatic lymph node ratio >0.30 of differentiated thyroid cancer predict response to radioactive iodine

Lymph node metastases >5 and metastatic lymph node ratio >0.30 of differentiated thyroid cancer predict response to radioactive iodine

Abstract Purpose The study was designed to elucidate the predictive value of the number of lymph node metastases (LNMs) and lymph node ratio (LNR) for response to therapy restratification system (RTRS). Methods From December 2015 to December 2019, 1228 patients who accepted radioactive iodine (RAI)...

Full description

Bibliographic Details
Main Authors:	Canhua Yun, Juan Xiao, Jingjia Cao, Chunchun Shao, Lihua Wang, Wei Zhang, Hongying Jia
Format:	Article
Language:	English
Published:	Wiley 2021-11-01
Series:	Cancer Medicine
Subjects:	classification tree differentiated thyroid cancer LNMs LNR radioactive iodine
Online Access:	https://doi.org/10.1002/cam4.4288

Similar Items

Management of hyperthyroidism with radioactive iodine
by: T Premprapha, et al.
Published: (2006-08-01)

N, LNR or LODDS: Which Is the Most Appropriate Lymph Node Classification Scheme for Patients with Radically Resected Pancreatic Cancer?
by: Dimitrios Prassas, et al.
Published: (2022-04-01)

Prognostic Discrimination of Alternative Lymph Node Classification Systems for Patients with Radically Resected Non-Metastatic Colorectal Cancer: A Cohort Study from a Single Tertiary Referral Center
by: Dimitrios Prassas, et al.
Published: (2021-08-01)

Role of Preoperative Peripheral Blood Inflammatory Parameters and Postoperative Lymph-node Ratio in Prognosis of Patients with Gastric Cancer Undergoing Chemotherapy
by: REN Wenzhen, et al.
Published: (2023-05-01)

Impact of lithium on radioactive iodine therapy for hyperthyroidism
by: Brahmanandam Lingudu, et al.
Published: (2014-01-01)

Low Iodine Diet for Preparation for Radioactive Iodine Therapy in Differentiated Thyroid Carcinoma in Korea
by: Jae Hoon Chung
Published: (2013-09-01)

The utility of sentinel Lymph node biopsy in the lateral neck in papillary thyroid carcinoma
by: Xing-qiang Yan, et al.
Published: (2022-07-01)

Efficacy and toxicity of Iodine-125 seed implantation for lymph node recurrence secondary to esophageal cancer after radiotherapy: a multicenter retrospective study
by: Lirong Wu, et al.
Published: (2023-01-01)

Delay of initial radioactive iodine therapy beyond 3 months has no effect on clinical responses and overall survival in patients with thyroid carcinoma: A cohort study and a meta‐analysis
by: Fang Cheng, et al.
Published: (2022-06-01)

Association between iodine nutrition and cervical lymph node metastasis of papillary thyroid microcarcinoma
by: Hengqiang Zhao, et al.
Published: (2023-08-01)

Lithium therapy: an unusual cause of elevated and diffuse radioactive iodine uptake.
by: Ebenezer A Nyenwe, et al.
Published: (2008-10-01)

Potential Impact of Body Mass Index on the Clinical Outcome of Papillary Thyroid Cancer After High-Dose Radioactive Iodine Therapy
by: Jingjia Cao, et al.
Published: (2022-05-01)

Removal of Radioactive Iodine Using Silver/Iron Oxide Composite Nanoadsorbents
by: Mah Rukh Zia, et al.
Published: (2021-02-01)

Lymph node ratio predicts efficacy of postoperative radiation therapy in nonmetastatic Merkel cell carcinoma: A population‐based analysis
by: Giuseppe Lamberti, et al.
Published: (2022-11-01)

The utility of low-iodine diet in preparation for thyroid cancer therapy with radioactive iodine—A cohort study
by: Hongxiu Luo, et al.
Published: (2022-09-01)

Predictors of thyroglobulin in the lymph nodes recurrence of papillary thyroid carcinoma undergoing total thyroidectomy
by: Zhichao Xing, et al.
Published: (2021-01-01)

Development and Validation of a New Lymph Node Ratio-Based Staging System for Ampullary Carcinoma After Curative Pancreaticoduodenectomy
by: Xiaojie Zhang, et al.
Published: (2022-01-01)

Lymph node ratio predicts recurrence-free survival and disease-specific survival of patients with pyriform sinus squamous cell carcinoma
by: Yunhe Liu, et al.
Published: (2023-06-01)

Radioactive Iodine Therapy and Glucose Tolerance
by: Roghaieh Samadi, et al.
Published: (2017-04-01)

Sarcoidosis mimicking metastatic thyroid cancer following radioactive iodine therapy
by: Zin W. Myint, et al.
Published: (2015-02-01)

Effect of liver dysfunction on outcome of radioactive iodine therapy for Graves’ disease
by: Yuyang Ze, et al.
Published: (2022-12-01)

Accurately Locating Metastatic Foci in Lymph Nodes With Lugol’s Iodine-Enhanced Micro-CT Imaging
by: Cheng-Wan Xia, et al.
Published: (2021-09-01)

Comparing the efficacy of thyroglobulin and thyroglobulin/ thyroid-stimulating hormone ratio models in predicting a successful response to radioactive iodine therapy
by: Yanli Ju, et al.
Published: (2023-01-01)

Control of iodine in the nuclear industry
Published: (1973)

Myeloid Neoplasia and Lymphoblastic Lymphoma with Eosinophilia After Radioactive Iodine: A Case Report
by: Mahmut Büyükşimşek, et al.
Published: (2018-03-01)

Case Report: A case of radioactive iodine-refractory thyroid cancer accompanying cervical lymph node metastasis treated with US-guided RFA combined with 125I seed implantation
by: Yuanpeng Zhai, et al.
Published: (2022-12-01)

Is postoperative radioactive iodine associated with a survival advantage among…
by: Hamed Rasha Hamdy
Published: (2017-06-01)

Acute myeloid leukemia following radioactive iodine therapy for papillary carcinoma of the thyroid
by: Jain Ankit, et al.
Published: (2009-06-01)

Predictive Role of Serum Thyroglobulin after Surgery and before Radioactive Iodine Therapy in Patients with Thyroid Carcinoma
by: Alberto Signore, et al.
Published: (2023-05-01)

CT‐guided iodine‐125 brachytherapy as salvage therapy for recurrent mediastinal lymph node metastasis
by: Hong Dong, et al.
Published: (2021-05-01)

Predictive factors for early hypothyroidism following the radioactive iodine therapy in Graves’ disease patients
by: Rui-Ting Hu, et al.
Published: (2020-05-01)

Modern therapy of radioactive iodine-refractory differentiated thyroid cancer: resolution of the Expert Council
by: P O Rumyantsev, et al.
Published: (2016-09-01)

Association between radioactive iodine uptake and neutropenia in untreated Graves’ disease
by: Qian Yang, et al.
Published: (2023-01-01)

Anaplastic Thyroid Carcinoma Following Radioactive Iodine Therapy for Graves' Disease
by: Sun Hwa Kim, et al.
Published: (2013-03-01)

Cost-Effectiveness Analysis of Antithyroid Drug (Propylthiouracil) Compared to Radioactive Iodine for the Treatment of Graves’ Disease in Ethiopia
by: Mengistu HS, et al.
Published: (2022-04-01)

Ultrasound and Sialendoscopy Findings in Radioactive Iodine–Induced Sialadenitis: Comparative Analysis and Possible Impact on Management
by: Michael Koch, et al.
Published: (2024-01-01)

Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients
by: Xiaoran Mei, et al.
Published: (2021-05-01)

A case of propylthiouracil-induced antineutrophilic cytoplasmic antibody-positive vasculitis successfully treated with radioactive iodine
by: C. Bes, et al.
Published: (2013-07-01)

Silver Nanomaterial-Immobilized Desalination Systems for Efficient Removal of Radioactive Iodine Species in Water
by: Ha Eun Shim, et al.
Published: (2018-08-01)

Ultrasound combined with Ki-67 to construct the prognostic model for radioactive iodine therapy outcomes in Graves’ disease patients
by: Yuegui Wang, et al.
Published: (2024-01-01)